07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
On October 29, 2019, the Seventh Circuit held that Burlington Northern Santa Fe Railway Company (“B...
Read More >
A plan’s definition of “compensation” tends to be one of the trickier aspects of 401(k) administr...
Read More >
Key Points - The Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 requires parties that m...
Read More >
Competition law enforcement agencies have undertaken many new initiatives focused on the digital eco...
Read More >
The deadline to register with OregonSaves for employers using professional employment organizations ...
Read More >
In the Matter of Giora Neeman v Town of Warwick, __AD3d__, 2020 NY Slip Op 03112, the Second Departm...
Read More >